Conatus Pharmaceuticals Inc (NASDAQ:CNAT) Stockholder Investigation over Possible Violations of Securities Laws
An investigation on behalf of investors of Conatus Pharmaceuticals Inc (NASDAQ:CNAT) shares over potential securities laws violations by Conatus Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced.
View full press release